Form 8-K Retrophin, Inc. For: Feb 27
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- Exclusive-Silver Lake in talks to buy Workday, sources say
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Citi agrees to acquire rewards platform Kard Financial
- Total darkness, then sunset as full eclipse wows spectators in Spain
- Burry doubles down on Nebius short after stock surges 34% on earnings
Retrophin (RTRX) Reports Q4 Loss of $0.36
March 5, 2015 4:17 PM ESTRetrophin (NASDAQ: RTRX) reported Q4 EPS of ($0.36), versus ($0.46) reported last year. Revenue for the quarter came in at $14.1 million, versus $0 reported last year.
For earnings history and earnings-related data on Retrophin (RTRX) click here.
... MoreRetrophin (RTRX) Receives Nasdaq 'Letter of Reprimand'
March 3, 2015 6:22 AM ESTRetrophin (NASDAQ: RTRX) disclosed the following today:
Item 3.01Notice of Delisting or Failure to Satisfy a Continued Listing Rule or... More